We next assessed the antiproliferative effects of nintedanib against a series of GIST cell lines and human primary GIST cells derived from three GIST patients expressing KIT wt, KIT‐V559D or KIT‐K642E mutations. Here, KIT is linked to gastrointestinal stromal tumor.